Tech Company Financing Transactions
Aspen Neuroscience Funding Round
On 4/2/2020, Aspen Neuroscience raised $70 million in Series A funding from OrbiMed, Arch Venture Partners and Domain Associates.
Transaction Overview
Company Name
Announced On
4/2/2020
Transaction Type
Venture Equity
Amount
$70,000,000
Round
Series A
Investors
OrbiMed (Lead Investor) (Peter Thompson)
private investors (Sam Altman)
Proceeds Purpose
The funding will support the completion of all remaining IND-enabling studies and FDA submission of the IND relating to Aspen's lead product (ANPD001), as well as the recruitment and screening of a trial-ready cohort of persons with Parkinson disease and the manufacture of their cells for the lead product.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10835 Rd. to the Cure 100
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Not Recorded
Overview
Aspen is developing enabling technologies for patient-specific induced pluripotent stem cell-based therapies.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 4/1/2020: Orum venture capital transaction
Next: 4/2/2020: iTeos Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs